Steven Kyle Grinspoon
Steven Kyle Grinspoon publishes mostly in Emergency Medicine, Endocrinology, Diabetes and Metabolism and Cardiology and Cardiovascular Medicine, on topics such as HIV-related health complications and treatments, HIV Research and Treatment and HIV/AIDS drug development and treatment.
- World rank
- #43,238 of 7,710,434 ranked researchers
- Rank in United States
- #16,624 of 1,627,098
- Works
- 513
- Citations
- 36k
- Citations per work
- 69.4
What does Steven Kyle Grinspoon research?
Steven Kyle Grinspoon's work is mostly in Medicine (53%), Immunology and Microbiology (7%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences27353.2%
- Medicine27353.2%
- Everything else20640.2%
- Life Sciences346.6%
- 1Emergency Medicine22% of their works
- 2Endocrinology, Diabetes and Metabolism11% of their works
- 3Cardiology and Cardiovascular Medicine7% of their works
- 4Infectious Diseases7% of their works
- 5Virology7% of their works
- 6Physiology6% of their works
Research topics
- HIV-related health complications and treatments
- HIV Research and Treatment
- HIV/AIDS drug development and treatment
- Cardiovascular Disease and Adiposity
- Lipoproteins and Cardiovascular Health
- Adipokines, Inflammation, and Metabolic Diseases
- Growth Hormone and Insulin-like Growth Factors
- Diabetes, Cardiovascular Risks, and Lipoproteins
Which keywords describe Steven Kyle Grinspoon's research?
The keywords of their largest research topics: Antiretroviral Therapy, Cardiovascular Disease, Inflammation, Insulin Resistance, HIV Infection, Aging, Metabolic Abnormalities and Obesity.
- Diabetes
- IGF-1
- Adipokines
- Cholesterol-lowering
- Epicardial Fat
- Drug Resistance
- HIV
- C-Reactive Protein
- Obesity
- Aging
- Insulin Resistance
- Cardiovascular Disease
- Antiretroviral Therapy
- Inflammation
- HIV Infection
- Metabolic Abnormalities
- Atherosclerosis
- AIDS
- Metabolic Syndrome
- Integrase Inhibitors
- Perivascular Adipose Tissue
- Statins
- Adipose Tissue
- Insulin-like Growth Factors
- Glucose Metabolism
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 25 words, with their numbers
- Antiretroviral Therapy4933 topics
- Cardiovascular Disease4784 topics
- Inflammation4353 topics
- Insulin Resistance4153 topics
- HIV Infection3972 topics
- Aging3261 topic
- Metabolic Abnormalities3261 topic
- Obesity1523 topics
- Atherosclerosis1062 topics
- C-Reactive Protein1002 topics
- AIDS961 topic
- HIV961 topic
- Metabolic Syndrome892 topics
- Drug Resistance711 topic
- Integrase Inhibitors711 topic
- Epicardial Fat631 topic
- Perivascular Adipose Tissue631 topic
- Cholesterol-lowering541 topic
- Statins541 topic
- Adipokines461 topic
- Adipose Tissue461 topic
- IGF-1441 topic
- Insulin-like Growth Factors441 topic
- Diabetes431 topic
- Glucose Metabolism431 topic
Where does Steven Kyle Grinspoon work?
Steven Kyle Grinspoon's main affiliation in the publication record is Massachusetts General Hospital, United States.
How many publications and citations does Steven Kyle Grinspoon have?
OpenAlex counts 513 works and 35,618 citations for Steven Kyle Grinspoon, an h-index of 98, ranking #43,238 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Steven Kyle Grinspoon. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.